NeuroEvidence: Limited5 min read

Selank: Reading a Research Base That Is Mostly Not in English

Selank has a real clinical literature. The problem is that most Western readers cannot access it, which creates an unusually large gap between what is claimed and what can be independently verified.

10mg

Typical vial

$20

Lowest tracked

$31

Median price

87

Vendors listing

Provenance of the evidence

Selank is a synthetic analogue of the immunomodulatory peptide tuftsin, developed in Russia. Our index references around 41 studies, the majority published in Russian-language journals with limited independent replication elsewhere.

That is why the evidence grade is Limited: it reflects verifiability, not an assumption that the work is wrong.

Selank and Semax

The two are routinely mentioned together and share a development lineage, but they are different sequences studied for different endpoints. Vendor pages that treat them as variations of one product are not reliable sources.

Pricing

10mg vials typically run £16 to £24. Fewer vendors list Selank than the major categories, so price coverage in our index is thinner.

What to check

Confirm whether the listing is Selank or N-acetyl Selank amidate, a modified version with different stability characteristics that is frequently sold under the plain name.

Frequently asked

Why is the evidence graded Limited when clinical studies exist?

Because independent, accessible replication is scarce. Grade reflects verifiability as well as volume.

Search focus for this profile

selank14,800/mo searches, difficulty 28/100 — easy. Source: Semrush (UK database).

Supporting terms covered: selank review, selank vs semax, anxiolytic peptide research.

Everything below describes published research and market data. Nothing here is medical advice, and none of these compounds are sold or supplied by CheckALab.

More in Neuro